SIRT7 and sarcoma: Importantly, however, our finding that SIRT7 affects the invasive properties ofHT1080 sarcoma cells (Fig. 2E–G) suggests thatSIRT7 must also impinge on metastasis regulatory pathways that operate inmesenchymal cancers, independent of EMT.